» Authors » Nathan Robbins

Nathan Robbins

Explore the profile of Nathan Robbins including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 424
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta N, Zhang B, Zhou Y, McCormack F, Ingledue R, Robbins N, et al.
Chest . 2023 Jan; 163(5):1144-1155. PMID: 36642366
Background: A critical need exists to develop remission-inducing therapies for lymphangioleiomyomatosis. Research Question: Is the addition of resveratrol safe and more efficacious than sirolimus alone in patients with lymphangioleiomyomatosis? Study...
2.
Rubinstein J, Robbins N, Evans K, Foster G, McConeghy K, Onadeko T, et al.
Trials . 2022 Apr; 23(1):266. PMID: 35392963
Background: Improving contractility in heart failure with reduced ejection fraction (HFrEF) has resurfaced as a potential treatment goal. Inotropic therapy is now better understood through its underlying mechanism as opposed...
3.
Kirschner A, Koch S, Robbins N, Karthik F, Mudigonda P, Ramasubramanian R, et al.
Cardiovasc Toxicol . 2021 Jul; 21(11):889-900. PMID: 34324134
Complete vascular occlusion to distant tissue prior to an ischemic cardiac event can provide significant cardioprotection via remote ischemic preconditioning (RIPC). Despite understanding its mechanistic basis, its translation to clinical...
4.
OConnor B, Robbins N, Koch S, Rubinstein J
Prog Biophys Mol Biol . 2020 Jun; 159:118-125. PMID: 32565182
The transient receptor potential (TRP) ion channel family is composed of twenty-seven channel proteins that are ubiquitously expressed in the human body. The TRPV (vanilloid) subfamily has been a recent...
5.
Onusko E, McDermott M, Robbins N, Liu G, Kranias E, Rubinstein J, et al.
PLoS One . 2020 Mar; 15(3):e0230386. PMID: 32218573
Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via stimulation of the transient...
6.
Li Y, Deng S, Wang X, Huang W, Chen J, Robbins N, et al.
Cardiovasc Res . 2020 Mar; 117(3):890-902. PMID: 32170929
Aims: Cardiac dysfunction is a prevalent comorbidity of disrupted inflammatory homeostasis observed in conditions such as sepsis (acute) or obesity (chronic). Secreted and transmembrane protein 1a (Sectm1a) has previously been...
7.
Robbins N, Hooker E, Hart K, Kapur S, Blomkalns A
Cardiol J . 2020 Jan; 26(6):802-804. PMID: 31970740
No abstract available.
8.
Horimatsu T, Blomkalns A, Ogbi M, Moses M, Kim D, Patel S, et al.
Cardiovasc Res . 2019 Nov; 116(14):2226-2238. PMID: 31710686
Aims: Chronic adventitial and medial infiltration of immune cells play an important role in the pathogenesis of abdominal aortic aneurysms (AAAs). Nicotinic acid (niacin) was shown to inhibit atherosclerosis by...
9.
Gardner G, Travers J, Qian J, Liu G, Haghighi K, Robbins N, et al.
JACC Basic Transl Sci . 2019 May; 4(2):188-199. PMID: 31061921
Cardiomyocyte-specific increases in phosphorylated Hsp20 (S16D-Hsp20) to levels similar to those observed in human failing hearts are associated with early fibrotic remodeling and depressed left ventricular function, symptoms which progress...
10.
Green L, Anthony S, Slone S, Lanzillotta L, Nieman M, Wu X, et al.
JCI Insight . 2019 Jan; 4(4). PMID: 30668549
RNA binding proteins represent an emerging class of proteins with a role in cardiac dysfunction. We show that activation of the RNA binding protein human antigen R (HuR) is increased...